Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof

Christian Lanctot; Pierre Moffatt; Gethin Thomas

Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof

Christian Lanctot (Inventor), Pierre Moffatt (Inventor), Gethin Thomas (Inventor)

Research output: Patent

Abstract

A method of using an osteocrin (Ostn) or a NPR-C specific Ostn peptide derivative for increasing osteogenesis in a mammal comprising administering a therapeutically effective amount of said Ostn or NPR-C specific Ostn peptide derivative to the mammal.

Original language	Undefined/Unknown
Patent number	US7470668 B2
Priority date	23/08/05
Publication status	Published - 30 Dec 2008

Access to Document

https://www.google.com/patents/US20070049521

Cite this

@misc{457a2682b2d34f699f34a549043c055a,

title = "Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof",

abstract = "A method of using an osteocrin (Ostn) or a NPR-C specific Ostn peptide derivative for increasing osteogenesis in a mammal comprising administering a therapeutically effective amount of said Ostn or NPR-C specific Ostn peptide derivative to the mammal.",

author = "Christian Lanctot and Pierre Moffatt and Gethin Thomas",

note = "US Patent 7,470,668; US7470668 B2",

year = "2008",

month = dec,

day = "30",

language = "Undefined/Unknown",

type = "Patent",

}

TY - PAT

T1 - Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof

AU - Lanctot, Christian

AU - Moffatt, Pierre

AU - Thomas, Gethin

N1 - US Patent 7,470,668

PY - 2008/12/30

Y1 - 2008/12/30

N2 - A method of using an osteocrin (Ostn) or a NPR-C specific Ostn peptide derivative for increasing osteogenesis in a mammal comprising administering a therapeutically effective amount of said Ostn or NPR-C specific Ostn peptide derivative to the mammal.

AB - A method of using an osteocrin (Ostn) or a NPR-C specific Ostn peptide derivative for increasing osteogenesis in a mammal comprising administering a therapeutically effective amount of said Ostn or NPR-C specific Ostn peptide derivative to the mammal.

M3 - Patent

M1 - US7470668 B2

ER -